Reaction Details |
| Report a problem with these data |
Target | Cytochrome P450 2C19 |
---|
Ligand | BDBM50313661 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_624626 (CHEMBL1111586) |
---|
IC50 | >10000±n/a nM |
---|
Citation | Lesuisse, D; Tiraboschi, G; Krick, A; Abecassis, PY; Dutruc-Rosset, G; Babin, D; Halley, F; Châtreau, F; Lachaud, S; Chevalier, A; Quarteronet, D; Burgevin, MC; Amara, C; Bertrand, P; Rooney, T Design of potent and selective GSK3beta inhibitors with acceptable safety profile and pharmacokinetics. Bioorg Med Chem Lett20:2344-9 (2010) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cytochrome P450 2C19 |
---|
Name: | Cytochrome P450 2C19 |
Synonyms: | (R)-limonene 6-monooxygenase | (S)-limonene 6-monooxygenase | (S)-limonene 7-monooxygenase | CP2CJ_HUMAN | CYP2C19 | CYPIIC17 | CYPIIC19 | Cytochrome P450 2C19 (CYP2C19) | Cytochrome P450 2C19 [I331V] | Cytochrome P450-11A | Cytochrome P450-254C | Fenbendazole monooxygenase (4'-hydroxylating) | Mephenytoin 4-hydroxylase | P450-11A | P450-254C |
Type: | Enzyme |
Mol. Mass.: | 55935.47 |
Organism: | Homo sapiens (Human) |
Description: | P33261 |
Residue: | 490 |
Sequence: | MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKI
YGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRW
KEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS
IIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFM
ESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTE
TTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRGHMPYTDAVVHEVQRYID
LIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFK
KSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVP
PFYQLCFIPV
|
|
|
BDBM50313661 |
---|
n/a |
---|
Name | BDBM50313661 |
Synonyms: | CHEMBL1095040 | N-(6-chloro-5-phenyl-1H-indazol-3-yl)butanamide | N-(6-chloro-5-phenyl-1H-indazol-3-yl)butyramide |
Type | Small organic molecule |
Emp. Form. | C17H16ClN3O |
Mol. Mass. | 313.781 |
SMILES | CCCC(=O)Nc1n[nH]c2cc(Cl)c(cc12)-c1ccccc1 |
Structure |
|